J. Blanchard

发表

Relationship Between Urine Flow Rate and Renal Clearance of Caffeine in Man

J. Blanchard, S. A. Sawers, S. Sawers, 1983, Journal of clinical pharmacology.

Influence of degree of substitution of cyclodextrins on their colligative properties in solution.

J. Blanchard, S. Proniuk, 2001, Journal of pharmaceutical sciences.

Development and Testing of an Improved Parenteral Formulation of Phenytoin Using 2-Hydroxypropyl-β-cyclodextrin

R. Dorr, J. Blanchard, S. Ugwu, 2000 .

Controlled‐release delivery system for the α‐MSH analog Melanotan‐I using poloxamer 407

R. Bhardwaj, J. Blanchard, 1996 .

In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine.

J. Blanchard, S. D. Desai, 1998, Journal of pharmaceutical sciences.

Discovery and development of novel melanogenic drugs. Melanotan-I and -II.

V. Hruby, R. Dorr, J. Blanchard, 1998, Pharmaceutical biotechnology.

Some Important Considerations in the Use of Cyclodextrins

J. Blanchard, S. Proniuk, 1999, Pharmaceutical Research.

Effects of gender on vitamin C pharmacokinetics in man.

J. Blanchard, 1991, Journal of the American College of Nutrition.

Vitamin C disposition in young and elderly men.

R. A. Mead, P. Garry, J. Blanchard, 1990, The American journal of clinical nutrition.

Determination of the partition coefficients, acid dissociation constants, and intrinsic solubility of carbenoxolone.

J. Blanchard, J. Boyle, S. Van Wagenen, 1988, Journal of pharmaceutical sciences.

Best Practices for Managing Quality and Safety of Foreign Particles in Orally Inhaled and Nasal Drug Products, and an Evaluation of Clinical Relevance

C. Crim, J. Blanchard, L. Nagao, 2007, Pharmaceutical Research.

Anhydrous Carbopol® Polymer Gels for the Topical Delivery of Oxygen/Water Sensitive Compounds

J. Blanchard, S. Proniuk, 2002, Pharmaceutical development and technology.

Characterization of the complexation of diflunisal with hydroxypropyl-beta-cyclodextrin.

R. Bhardwaj, J. Blanchard, S. Ugwu, 1999, Journal of pharmaceutical and biomedical analysis.

The application of equilibrium dialysis to the determination of drug-cyclodextrin stability constants

J. Blanchard, S. Ugwu, M. J. Alcala, 1996 .

Comparison of methods for estimating body composition in young and elderly women.

J. Blanchard, G. Harrison, K. Conrad, 1990, Journal of gerontology.

Depletion and repletion kinetics of vitamin C in humans.

J. Blanchard, James Blanchard, 1991, The Journal of nutrition.

Protein binding of caffeine in young and elderly males.

J. Blanchard, 1982, Journal of pharmaceutical sciences.

Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention.

B. Liederer, J. Blanchard, S. Proniuk, 2002, Journal of pharmaceutical sciences.

Cardiovascular Effects of Caffeine in Elderly Men

J. Blanchard, K. Conrad, J. Trang, 1982, Journal of the American Geriatrics Society.

Comparison of the urinary metabolite profile of caffeine in young and elderly males.

J. Blanchard, D. Tang-Liu, J. Jonkman, 1985, British journal of clinical pharmacology.

The effect of vitamin C on the pharmacokinetics of caffeine in elderly men.

J. Blanchard, G. Harrison, K. Conrad, 1982, The American journal of clinical nutrition.

Methylxanthine levels in breast milk of lactating women of different ethnic and socioeconomic classes

J. Blanchard, Charles W. Webr, L. Shearer, 1992, Biopharmaceutics & drug disposition.

Comparison of plasma, mononuclear and polymorphonuclear leucocyte vitamin C levels in young and elderly women during depletion and supplementation.

R. Watson, P. Garry, J. Blanchard, 1989, European journal of clinical nutrition.

The influence of vitamin C on antipyrine pharmacokinetics in elderly men.

J. Blanchard, G. Harrison, K. Conrad, 1984, Biopharmaceutics & drug disposition.

An Improved Method for Determination of Acid Dissociation Constants of Peptides

Q. Fernaǹdo, J. Blanchard, X. Fang, 1995, Pharmaceutical Research.

Effect of pH on theophylline transfer across the everted rat jejunum.

P. Walson, J. Blanchard, D. Perry, 1984, Journal of pharmaceutical sciences.

In vitro evaluation of Poly(D,L-lactide-co-glycolide) polymer-based implants containing the α-melanocyte stimulating hormone analog, Melanotan-I

R. Bhardwaj, J. Blanchard, 1997 .

Approaches to reducing toxicity of parenteral anticancer drug formulations using cyclodextrins.

R. Dorr, R. Bhardwaj, J. Blanchard, 2000, PDA journal of pharmaceutical science and technology.

Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model.

J. Blanchard, S. D. Desai, 1998, Journal of pharmaceutical sciences.

Effect of Temperature and Light on the Stability of Latanoprost and its Clinical Relevance

R. Noecker, J. Blanchard, S. Proniuk, 2001, Journal of glaucoma.

Topical formulation studies with DEET (N,N-diethyl-3-methylbenzamide) and cyclodextrins.

M. Kallen, B. Liederer, J. Blanchard, 2002, Journal of pharmaceutical sciences.

Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407.

R. Bhardwaj, J. Blanchard, 1996, Journal of pharmaceutical sciences.

A simplified and rapid high-performance liquid chromatographic assay for ketoprofen in isopropyl myristate.

J. Blanchard, S. Proniuk, S. Lerkpulsawad, 1998, Journal of chromatographic science.

Pharmacokinetic perspectives on megadoses of ascorbic acid.

M. Rowland, J. Blanchard, T. Tozer, 1997, The American journal of clinical nutrition.

High-performance liquid chromatographic assay for the alpha-melanotropin[4,10] fragment analogue (Melanotan-II) in rat plasma.

J. Blanchard, S. Ugwu, 1992, Journal of chromatography.

Effect of polyols on interaction of paraben preservatives with polysorbate 80.

J. Blanchard, 1980, Journal of pharmaceutical sciences.

Pharmacologic Response of a Controlled-Release PLGA Formulation for the Alpha-Melanocyte Stimulating Hormone Analog, Melanotan-I

R. Dorr, R. Bhardwaj, J. Blanchard, 2000, Pharmaceutical Research.

In vitro characterization and in vivo release profile of a poly (d,l-lactide-co-glycolide)-based implant delivery system for the α-MSH analog, melanotan-I

R. Bhardwaj, J. Blanchard, 1998 .

A comparison of HPLC and bioassay methods for plasma melanotan‐II (MT‐II) determination: Application to a pharmacokinetic study in rats

J. Blanchard, L. Nguyen, Sydney O. Ugwu, 1994, Biopharmaceutics & drug disposition.

High-performance liquid chromatographic assay for Melanotan-1 ([Nle4-DPhe7]alpha-melanocyte-stimulating hormone) in biological matrices.

J. Blanchard, N. Surendran, S. Ugwu, 1995, Journal of chromatography. B, Biomedical applications.

Absorption enhancement of melanotan-l: comparison of the caco-2 and rat in situ models

R. Dorr, J. Blanchard, N. Surendran, 1995 .

Preformulation studies with melanotan-II: a potential skin cancer chemopreventive peptide.

V. Hruby, J. Blanchard, S. Ugwu, 1994, Journal of pharmaceutical sciences.

Kinetics of degradation of a cyclic lactam analog of α-melanotropin (MT-II) in aqueous solution

V. Hruby, J. Blanchard, S. Ugwu, 1994 .

Investigation of drug-albumin interactions using spin-labeled bovine serum albumin.

J. Blanchard, T. Tozer, L. Tuck, 1975, Molecular pharmacology.

HPLC analysis of methylxanthines in human breast milk.

J. Blanchard, C. Weber, L. Shearer, 1990, Journal of chromatographic science.

A simplified and rapid high-performance liquid chromatographic assay for pilocarpine hydrochloride

J. Blanchard, S. D. Desai, 1992 .

Relationship Between Serum and Saliva Theophylline Levels in Patients with Cystic Fibrosis

W. Morgan, J. Blanchard, S. Harvey, 1992, Therapeutic drug monitoring.

Factors influencing the transfer of xanthines across the everted rat jejunum

P. Walson, J. Blanchard, D. Perry, 1984 .

Comparative pharmacokinetics of caffeine in young and elderly men

James Blanchard, J. Blanchard, Stewart J. A. Sawers, 1983, Journal of Pharmacokinetics and Biopharmaceutics.

Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine.

J. Blanchard, S. D. Desai, 2000, Drug delivery.

Phase 1 Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer

D. Alberts, J. Ranger-Moore, R. Dorr, 2008, Nutrition and cancer.

Comparison of Ultrafiltration Devices for Assessing Theophylline Protein Binding

J. Blanchard, James Blanchard, S. Harvey, 1990, Therapeutic drug monitoring.

Drug-albumin interactions using spin labeling.

J. Blanchard, T. Tozer, L. Tuck, 1973, Journal of pharmaceutical sciences.

The effects of aging on the dissolution of phenytoin sodium capsule formulations

J. Blanchard, J. T. Rubino, Lisa M. Halterlein, 1985 .

Effect of sorbitol on interaction of phenolic preservatives with polysorbate 80.

J. Blanchard, W. Fink, J. Duffy, 1977, Journal of pharmaceutical sciences.

Calcium and osteoporosis: some caveats and pleas

J. Blanchard, 1989, Calcified Tissue International.

A study of cadmium transport pathways using the Caco-2 cell model.

J. Blanchard, H. Laird, E. A. Pigman, 1997, Toxicology and applied pharmacology.

The absolute bioavailability of caffeine in man

J. Blanchard, S. Sawers, 2004, European Journal of Clinical Pharmacology.

Effects of age and intake on vitamin C disposition in females.

P. Garry, J. Blanchard, K. Conrad, 1990, European journal of clinical nutrition.

Mechanisms of acylcarnitine-mediated enhancement of calcium transport in the Caco-2 cell monolayer model.

A. Giuliano, J. Blanchard, N. Surendran, 1995, Journal of pharmaceutical sciences.

A rapid and specific high-performance liquid chromatographic assay for theophylline in biological fluids.

J. Blanchard, W. Morgan, S. Harvey, 1990, Journal of chromatographic science.

Enhancement of calcium transport in the Caco-2 cell monolayer model.

A. Giuliano, J. Blanchard, N. Surendran, 1995, Journal of Pharmacy and Science.

Use of the Caco-2 cell model to assess the relative lead-chelating ability of diasterioisomers of 2,3-dimercaptosuccinic acid.

Q. Fernaǹdo, J. Blanchard, J. R. Lott, 1999, Environmental health perspectives.

Simplified method for intravenous dosing and serial blood sampling of unanesthetized guinea pigs.

J. Blanchard, D. Hochman, 1983, Journal of pharmaceutical sciences.

Calcium absorption in man: Some dosing recommendations

J. Blanchard, J. Aeschlimann, 1989, Journal of Pharmacokinetics and Biopharmaceutics.

Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.

J. Blanchard, W. Morgan, S. Harvey, 1992, British journal of clinical pharmacology.

Serum/Saliva Correlations for Theophylline in Asthmatics

J. Blanchard, S. Harvey, W. Morgan, 1991, Journal of clinical pharmacology.

Development of safety qualification thresholds and their use in orally inhaled and nasal drug product evaluation.

Roger O McClellan, David Jacobson-Kram, James Blanchard, 2007, Toxicological sciences : an official journal of the Society of Toxicology.

An improved permeability screening technique utilizing the in vitro rat intestine.

J. Blanchard, A. Straussner, 1977, Acta pharmaceutica Suecica.

Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease.

F. Camargo, R. Erickson, J. Blanchard, 2001, Life sciences.

Skin Pigmentation and Pharmacokinetics of Melanotan‐I in Humans

M. Aickin, V. Hruby, R. Dorr, 1997, Biopharmaceutics & drug disposition.

Comparison of the Hanson Microette® and the Van Kel Apparatus for In Vitro Release Testing of Topical Semisolid Formulations

Markus Rapedius, James Blanchard, Markus Rapedius, 2001, Pharmaceutical Research.

Relationship between total body clearance of caffeine and urine flow rate in elderly men.

J. Blanchard, G. Harrison, K. Conrad, 1985, Biopharmaceutics & drug disposition.

Elimination of a potential interference in assay for plasma caffeine.

J. Blanchard, J. Trang, J. D. Mohammadi, 1981, Clinical Chemistry.

Aqueous penetration of gatifloxacin and levofloxacin into the rabbit aqueous humor following topical dosing.

Markus Rapedius, R. Noecker, J. Blanchard, 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.